Filing Details
- Accession Number:
- 0001144204-11-040116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-12 12:25:28
- Reporting Period:
- 2011-07-08
- Filing Date:
- 2011-07-12
- Accepted Time:
- 2011-07-12 12:25:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
811641 | Immucell Corp | ICCC | In Vitro & In Vivo Diagnostic Substances (2835) | 010382980 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1384044 | Scott David Tomsche | C/O Immucell Corporation 56 Evergreen Drive Portland ME US 04103 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Per Value $0.10 Per Share | Acquisiton | 2011-07-08 | 1,000 | $6.66 | 36,795 | No | 4 | P | Direct | |
Common Stock, Per Value $0.10 Per Share | Acquisiton | 2011-07-11 | 567 | $6.53 | 37,362 | No | 4 | P | Direct | |
Common Stock, Per Value $0.10 Per Share | Acquisiton | 2011-07-11 | 100 | $6.50 | 37,462 | No | 4 | P | Direct | |
Common Stock, Per Value $0.10 Per Share | Acquisiton | 2011-07-12 | 206 | $6.80 | 37,668 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |